TAIHO PHARMA

Contact Us
Japanese
  • About Taiho
  • Our Business
  • Our Science
  • Product Lineup
  • News Releases

CLOSE

About Taiho

  • About Taiho TOP
  • Corporate Philosophy
  • President's Message
  • Corporate Data
  • Financial Highlights
  • Globalization
  • Major Subsidiaries
  • Corporate Social Responsibility
  • History
  • Otsuka Holdings Co., Ltd.

Our Business

  • Our Business TOP
  • Research & Development
  • Production
  • Marketing

Our Science

  • Our Science TOP
  • Product Pipeline
  • Discovery and Preclinical Research
  • Clinical Development
  • Policy
  • Exploring hidden
    possibilities for
    people awaiting
    new medicines

    sample

PREV
NEXT
  • We mourn the loss of those who have died from COVID-19, extend our sympathies to their loved ones, wish COVID-19 survivors rapid and permanent recoveries, and express our gratitude to medical professionals and others who support the ill.

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

  • RSS
  • More
  • April 02, 2021

    FDA Grants Breakthrough Therapy Designation for Taiho Pharmaceutical Originated Futibatinib for Treatment of Advanced Cholangiocarcinoma(PDF:433.6 KB)

  • March 23, 2021

    Taiho Pharmaceutical Submits New Drug Application for NK1 Receptor Antagonist Fosnetupitant for Prevention of Gastrointestinal Symptoms (Nausea and Vomiting) Associated with Cancer Chemotherapy

  • March 09, 2021

    Taiho Pharmaceutical Announces Personnel Changes(PDF:82.6 KB)

  • February 22, 2021

    Taiho Pharmaceutical's TAS-116, an Oral HSP90 Inhibitor, Shows Significantly Prolonged
    Progression-Free Survival in Patients with GIST in Phase-III Clinical Trial

  • February 09, 2021

    Office Divisions of Five Otsuka Group Companies to Switch to Green Power(PDF:102.5 KB)

Information

  • February 12, 2021

    Otsuka Holdings announces FY2020 financial results

  • July 12, 2018

    Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan(PDF:165.9 KB)

  • Terms of Use
  • Privacy Statement
  • Sitemap
  • Otsuka Otsuka Group
  • Otsuka Holdings
  • Otsuka Pharmaceutical
  • Otsuka Pharmaceutical Factory
  • Otsuka Warehouse
  • Otsuka Chemical
  • Otsuka foods
  • Otsuka Medical Devices

Copyright © TAIHO PHARMACEUTICAL CO., LTD. 2021 All rights reserved.